A case–control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) on 284 women with endometrial cancer found that women with MetS had a relative risk for endometrial cancer (HR = 2.12, 95% CI:1.51–2.97), and there was a positive trend in risk for patients with an increasing number of Mets components [ 53 ].
← all excerpts
Metabolic syndrome score as an indicator in a predictive nomogram for lymph node metastasis in endometrial cancer.
1
—
—